Elkayam Uri, Akhter Mohammed W, Singh Harpreet, Khan Salman, Usman Ahsan
Heart Failure Program, Division of Cardiovascular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.
Am J Cardiol. 2004 Jan 15;93(2):237-40. doi: 10.1016/j.amjcard.2003.09.051.
The results of this study showed an advantage of nesiritide compared with high-dose nitroglycerin in the treatment of patients with decompensated heart failure. Nesiritide resulted in an early decrease in pulmonary capillary wedge pressure (< or =15 minutes), which was sustained throughout the study period (24 hours) without the need for up-titration. In contrast, the onset of the nitroglycerin-mediated hemodynamic effect was delayed, and despite aggressive up-titration, the decrease in pulmonary capillary wedge pressure was gradually attenuated because of the early development of tolerance.
本研究结果显示,在治疗失代偿性心力衰竭患者方面,奈西立肽较高剂量硝酸甘油具有优势。奈西立肽可使肺毛细血管楔压早期降低(≤15分钟),且在整个研究期间(24小时)持续存在,无需上调剂量。相比之下,硝酸甘油介导的血流动力学效应起效延迟,尽管积极上调剂量,但由于早期出现耐受性,肺毛细血管楔压的降低逐渐减弱。